Ronald M Krauss

Q: What Schools Are Affiliated With Ronald M Krauss

Ronald M Krauss is affiliated with the following schools: University of California, Berkeley, Uppsala University, Wake Forest University, University of California, Los Angeles, University of Southern California, University of California, Davis, University System of Maryland, University of Oklahoma, University of California, San Francisco, University of Ottawa, Stanford University, University of Palermo, Lund University, Johns Hopkins University, University of Washington, Harvard University

Ronald M Krauss's AcademicInfluence.com Rankings

Ronald M Krauss

Philosophy

#2628

World Rank

#4432

Historical Rank

Logic

#681

World Rank

#1187

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Ronald M Krauss's Degrees

PhD Nutritional Sciences University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Ronald M Krauss Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ronald M Krauss's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) (7217)
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. (2005) (5418)
Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (2010) (3485)
Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis (2013) (3174)
Discovery and Refinement of Loci Associated with Lipid Levels (2013) (2475)
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial (1995) (2244)
Diagnosis and management of the metabolic syndrome (2005) (2066)
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel (2017) (1817)
Low-density lipoprotein subclass patterns and risk of myocardial infarction. (1988) (1793)
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. (2009) (1548)
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. (1990) (1426)
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. (2000) (1286)
Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. (2010) (1168)
A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. (1996) (1123)
American College of Endocrinology position statement on the insulin resistance syndrome. (2003) (1075)
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus (2010) (1048)
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary (2005) (1032)
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI (1991) (1024)
Identification of multiple subclasses of plasma low density lipoproteins in normal humans. (1982) (1010)
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management (2015) (980)
Low-density lipoproteins cause atherosclerotic cardiovascular disease (2018) (936)
An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing (2001) (923)
Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). (1994) (910)
Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. (1996) (905)
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. (2000) (900)
American Heart Association Call to Action: Obesity as a Major Risk Factor for Coronary Heart Disease (1998) (832)
Metabolic origins and clinical significance of LDL heterogeneity DOI 10.1194/jlr.R200004-JLR200 (2002) (824)
Common variants associated with plasma triglycerides and risk for coronary artery disease (2013) (767)
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (723)
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. (1993) (719)
Lipids and lipoproteins in patients with type 2 diabetes. (2004) (714)
INFERTILITY IN MALE PESTICIDE WORKERS (1977) (648)
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. (2001) (628)
Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. (1999) (615)
Population analysis of large copy number variants and hotspots of human genetic disease. (2009) (589)
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. (1993) (577)
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials (2015) (559)
Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. (1996) (554)
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? (2005) (546)
Saturated fat, carbohydrate, and cardiovascular disease. (2010) (544)
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel (2020) (541)
Nondenaturing polyacrylamide gradient gel electrophoresis. (1986) (516)
The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? (2011) (510)
Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. (2005) (502)
Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. (1992) (492)
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. (2004) (480)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel (2006) (478)
Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial (2006) (466)
Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. (1974) (456)
Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding. (1987) (454)
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. (1990) (448)
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. (2011) (441)
Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. (1978) (434)
Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. (1992) (421)
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. (2002) (415)
[8] Single vertical spin density gradient ultracentrifugation (1986) (401)
Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. (1983) (376)
Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200189-JLR200 (2002) (354)
The genetics of blood pressure regulation and its target organs from association studies in 342,415 individuals (2016) (347)
LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes. (1992) (344)
Heterogeneity of serum low density lipoproteins in normal human subjects. (1981) (338)
Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation. (2015) (334)
Saturated Fatty Acids and Risk of Coronary Heart Disease: Modulation by Replacement Nutrients (2010) (327)
Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. (2006) (323)
Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. (1999) (309)
The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. (1984) (307)
High-density lipoproteins: a consensus statement from the National Lipid Association. (2013) (293)
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges (2007) (286)
INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN (1987) (272)
Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. (1991) (271)
Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. (1990) (270)
Heterogeneity of plasma low‐density lipoproteins and atherosclerosis risk (1994) (255)
LDL Subclass Phenotypes and the Insulin Resistance Syndrome in Women (1993) (251)
Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2018) (245)
Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity (2017) (244)
Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia. (1983) (242)
A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk (2009) (241)
Genome-Wide Association of Lipid-Lowering Response to Statins in Combined Study Populations (2010) (238)
Obesity: impact of cardiovascular disease. (2000) (235)
Selective measurement of two different triglyceride lipase activities in rat postheparin plasma. (1973) (234)
When good drugs go bad (2007) (233)
American Heart Association call to action: obesity as a major risk factor for coronary heart disease. AHA Nutrition Committee. (1998) (231)
A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 Caucasians (2014) (228)
Lipoprotein subfractions and cardiovascular disease risk (2010) (225)
Atherogenicity of triglyceride-rich lipoproteins. (1998) (222)
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. (2018) (221)
Comparison of the DASH (Dietary Approaches to Stop Hypertension) diet and a higher-fat DASH diet on blood pressure and lipids and lipoproteins: a randomized controlled trial. (2016) (221)
Association of Body Mass Index with DNA Methylation and Gene Expression in Blood Cells and Relations to Cardiometabolic Disease: A Mendelian Randomization Approach (2017) (221)
Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract (2018) (221)
SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. (2013) (219)
Changes in lipoprotein subfractions during diet-induced and exercise-induced weight loss in moderately overweight men. (1990) (218)
Inheritance of low-density lipoprotein subclass patterns: results of complex segregation analysis. (1988) (215)
Saturated Fats Versus Polyunsaturated Fats Versus Carbohydrates for Cardiovascular Disease Prevention and Treatment. (2015) (215)
The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. (1993) (207)
Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins (2014) (207)
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy (2013) (206)
A PROPOSED GENETIC MARKER FOR CORONARY HEART DISEASE RISK (1990) (202)
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I. (2000) (200)
Saturated Fats and Health: A Reassessment and Proposal for Food-based Recommendations: JACC State-of -the-Art Review. (2020) (199)
AHA scientific statement: AHA dietary guidelines: Revision 2000: A statement for healthcare professionals from the nutrition committee of the American Heart Association (2001) (193)
Single vertical spin density gradient ultracentrifugation. (1986) (193)
Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein. (2008) (193)
Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance (2018) (193)
Regional adiposity patterns in relation to lipids, lipoprotein cholesterol, and lipoprotein subfraction mass in men. (1989) (192)
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. (2008) (191)
Low‐density lipoprotein subclass patterns and lipoprotein response to a reduced‐fat diet in men (1994) (190)
A large electronic health record-based genome-wide study of serum lipids (2018) (188)
Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS). Treatment effects and relation to coronary angiographic progression. (1996) (187)
Dietary and drug treatment of primary hyperlipoproteinemia. (1972) (186)
Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. (2006) (183)
Coronary Artery Disease Regression: Convincing Evidence for the Benefit of Aggressive Lipoprotein Management (1994) (180)
Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome (2017) (179)
Testicular function in DBCP exposed pesticide workers. (1979) (177)
Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. (1987) (177)
Multivariate analysis of the insulin resistance syndrome in women. (1994) (171)
Further Observations on the Activation and Inhibition of Lipoprotein Lipase by Apolipoproteins (1973) (171)
GENETIC CONTROL OF LOW-DENSITY-LIPOPROTEIN SUBCLASSES (1986) (170)
Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. (1998) (170)
The case for strategic international alliances to harness nutritional genomics for public and personal health† (2005) (170)
Predominance of dense low-density lipoprotein particles predicts angiographic benefit of therapy in the Stanford Coronary Risk Intervention Project. (1996) (169)
Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins. (2001) (169)
Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19. (1992) (168)
Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and alpha-tocopherol content. (1994) (167)
Pharmacogenomics: Challenges and Opportunities (2006) (162)
Lipoprotein subfractions of runners and sedentary men. (1986) (160)
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts (2011) (159)
Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment (2011) (156)
Dense low density lipoproteins and coronary artery disease. (1995) (156)
Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. (1997) (153)
Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health: Conference Summary From the Nutrition Committee of the American Heart Association (2001) (151)
Ion Mobility Analysis of Lipoprotein Subfractions Identifies Three Independent Axes of Cardiovascular Risk (2009) (150)
Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. (1994) (150)
A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. (1999) (150)
Variation in the 3-Hydroxyl-3-Methylglutaryl Coenzyme A Reductase Gene Is Associated With Racial Differences in Low-Density Lipoprotein Cholesterol Response to Simvastatin Treatment (2008) (147)
Clinical implications of pharmacogenomics of statin treatment (2006) (145)
Detection and quantitation of LDL subfractions (1992) (145)
Differential effects of nicotinic acid in subjects with different LDL subclass patterns. (1992) (141)
Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With Replication (2008) (141)
Triglycerides and atherogenic lipoproteins: rationale for lipid management. (1998) (137)
Protein in optimal health: heart disease and type 2 diabetes. (2008) (136)
Proprotein convertase subtilisin/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk. (2015) (135)
The effects of polyunsaturated fat vs monounsaturated fat on plasma lipoproteins. (1990) (133)
Dyslipidemia in type 2 diabetes. (2004) (132)
Structural basis of transfer between lipoproteins by cholesteryl ester transfer protein. (2012) (131)
Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. (1995) (131)
Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. (2008) (130)
The power of genetic diversity in genome-wide association studies of lipids (2021) (129)
MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. (2011) (129)
A biochemical and morphologic study of very low density lipoproteins in carbohydrate-induced hypertriglyceridemia. (1971) (127)
Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein (1999) (127)
Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. (2001) (126)
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men (2002) (125)
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors (2019) (124)
Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins (1990) (123)
Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin (2008) (122)
X-linked ichthyosis: increased blood cholesterol sulfate and electrophoretic mobility of low-density lipoprotein. (1981) (121)
WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach? (2019) (118)
Differences in receptor binding of LDL subfractions. (1996) (118)
Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. (2019) (116)
Dietary and genetic probes of atherogenic dyslipidemia. (2005) (115)
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. (1992) (114)
Characterization, subcellular localization, and partial purification of a heparin-released triglyceride lipase from rat liver. (1973) (114)
Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). (2000) (113)
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice. (2002) (112)
Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. (1995) (111)
Atherogenic lipoprotein phenotype and diet-gene interactions. (2001) (111)
Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. (1990) (110)
Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. (1995) (109)
Heritability of factors of the insulin resistance syndrome in women twins (1997) (109)
Association of the APOLIPOPROTEIN A1/C3/A4/A5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia (2004) (108)
Dietary and genetic effects on low-density lipoprotein heterogeneity. (2001) (107)
Metabolic abnormalities: triglyceride and low-density lipoprotein. (2004) (106)
Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. (1997) (104)
Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk. (1994) (103)
Multilocus genetic determinants of LDL particle size in coronary artery disease families. (1996) (102)
Regulation of high density lipoprotein levels. (1982) (102)
Lipidomic analysis of variation in response to simvastatin in the Cholesterol and Pharmacogenetics Study (2010) (101)
Relationships of plasma estradiol, testosterone, and sex hormone-binding globulin with lipoproteins, apolipoproteins, and high density lipoprotein subfractions in men. (1987) (101)
Does weight loss cause the exercise-induced increase in plasma high density lipoproteins? (1983) (98)
Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women. (1992) (98)
Genetic predictors of FCHL in four large pedigrees. Influence of ApoB level major locus predicted genotype and LDL subclass phenotype. (1994) (97)
Identifying the predominant peak diameter of high-density and low-density lipoproteins by electrophoresis. (1990) (97)
Lipoprotein subspecies and risk of coronary disease. (1988) (96)
Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. (1992) (96)
Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis. (1993) (95)
Presence of Multiple Subpopulations of Lipoproteins of Intermediate Density in Normal Subjects (1986) (91)
Interrelationships among subgroups of serum lipoproteins in normal human subjects. (1980) (91)
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan Published, JLR Papers in Press, September 1, 2002. DOI 10.1194/jlr.M200322-JLR200 (2002) (90)
Pharmacogenomics of statin response (2007) (89)
Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies (2017) (87)
Metabolomics Reveals Amino Acids Contribute to Variation in Response to Simvastatin Treatment (2012) (87)
The tangled web of coronary risk factors. (1991) (85)
Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. (1992) (84)
Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib[S] (2012) (84)
Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk (2016) (82)
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges (2008) (82)
AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association. (2001) (81)
Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. (1998) (81)
LDL physical and chemical properties in familial combined hyperlipidemia. (1995) (80)
Sulfur K-edge x-ray absorption spectroscopy: a spectroscopic tool to examine the redox state of S-containing metabolites in vivo. (1998) (80)
Comparison of four methods of analysis of lipoprotein particle subfractions for their association with angiographic progression of coronary artery disease. (2014) (80)
Effects of weight-loss by exercise and by diet on apolipoproteins A-I and A-II and the particle-size distribution of high-density lipoproteins in men. (1992) (80)
Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia. (2000) (80)
Influence of dietary carbohydrate and fat on LDL and HDL particle distributions (2005) (80)
Association Between Angiotensinogen, Angiotensin II Receptor Genes, and Blood Pressure Response to an Angiotensin-Converting Enzyme Inhibitor (2007) (80)
The metabolic impact of oral contraceptives. (1992) (80)
Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women. (1993) (79)
Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins. (1998) (79)
Odd Chain Fatty Acids; New Insights of the Relationship Between the Gut Microbiota, Dietary Intake, Biosynthesis and Glucose Intolerance (2017) (79)
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial (2015) (78)
Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins. (1988) (77)
Tracing Sub-Structure in the European American Population with PCA-Informative Markers (2008) (77)
Bimodality of plasma apolipoprotein B levels in familial combined hyperlipidemia. (1992) (77)
Vaccenic acid and trans fatty acid isomers from partially hydrogenated oil both adversely affect LDL cholesterol: a double-blind, randomized controlled trial. (2015) (76)
Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. (2000) (76)
Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. (1995) (75)
Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced oxidation among LDL density subfractions. (1995) (74)
Families with familial combined hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype. (1998) (73)
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. (2012) (72)
Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. (1985) (72)
Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition. (1990) (71)
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary. (2020) (71)
Effects of red meat, white meat, and nonmeat protein sources on atherogenic lipoprotein measures in the context of low compared with high saturated fat intake: a randomized controlled trial. (2019) (71)
Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet (2010) (69)
Effects of exercise-induced weight loss on low density lipoprotein subfractions in healthy men. (1989) (69)
Correlations of plasma lipoproteins with LDL subfractions by particle size in men and women. (1992) (68)
Combined Influence of LDLR and HMGCR Sequence Variation on Lipid-Lowering Response to Simvastatin (2010) (68)
The carbohydrate-insulin model: a physiological perspective on the obesity pandemic (2021) (68)
VLDL hydrolysis by LPL activates PPAR-α through generation of unbound fatty acids (2010) (67)
LDL subclass patterns and lipoprotein response to a low-fat, high-carbohydrate diet in women. (1997) (67)
Effects of a very high saturated fat diet on LDL particles in adults with atherogenic dyslipidemia: A randomized controlled trial (2017) (67)
Low-density lipoprotein subclasses and risk of coronary artery disease (1991) (66)
Coordinately Regulated Alternative Splicing of Genes Involved in Cholesterol Biosynthesis and Uptake (2011) (65)
Diet, lipids, and cardiovascular disease (2016) (65)
Coordinate Changes in Levels of HSuman Serum Low and High Density Lipoprotein Subclasses in Healthy Men (1988) (64)
Effects of low-fat diet, calorie restriction, and running on lipoprotein subfraction concentrations in moderately overweight men. (1994) (64)
Hepatic nuclear factor 1-α: inflammation, genetics, and atherosclerosis (2009) (64)
Organophosphorus Flame Retardants Inhibit Specific Liver Carboxylesterases and Cause Serum Hypertriglyceridemia (2014) (63)
Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey. (1988) (62)
Impact of Individual Traits, Saturated Fat, and Protein Source on the Gut Microbiome (2018) (61)
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. (2015) (60)
Cryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moiety. (1997) (60)
Defective catabolism and abnormal composition of low-density lipoproteins from mutant pigs with hypercholesterolemia. (1988) (59)
Metagenomic Insights into the Degradation of Resistant Starch by Human Gut Microbiota (2018) (58)
Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins (2008) (58)
LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins (2018) (58)
Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories (2018) (58)
High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation (2020) (57)
Subdermal estradiol pellets following hysterectomy and oophorectomy. Effect upon serum estrone, estradiol, luteinizing hormone, follicle-stimulating hormone, corticosteroid binding globulin-binding capacity, testosterone-estradiol binding globulin-binding capacity, lipids, and hot flushes. (1980) (56)
Familial apolipoprotein AI and apolipoprotein CIII deficiency. Subclass distribution, composition, and morphology of lipoproteins in a disorder associated with premature atherosclerosis. (1984) (56)
Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors. (1999) (56)
Diet-gene interactions in human lipoprotein metabolism. (1997) (56)
Effect of fluvastatin on low-density lipoprotein peak particle diameter. (1997) (56)
Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. (1993) (55)
Trans-ethnic Meta-analysis and Functional Annotation Illuminates the Genetic Architecture of Fasting Glucose and Insulin. (2016) (54)
Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The JUPITER Trial (2015) (54)
Structural heterogeneity of apoB-containing serum lipoproteins visualized using cryo-electron microscopy. (1999) (52)
PCSK9 deficiency reduces atherosclerosis, apolipoprotein B secretion, and endothelial dysfunction[S] (2017) (52)
Genetic variation in PNPLA3 but not APOC3 influences liver fat in non‐alcoholic fatty liver disease (2012) (52)
The role of HMGCR alternative splicing in statin efficacy. (2009) (52)
Role of CYP27A in cholesterol and bile acid metabolism Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400219-JLR200 (2005) (51)
Hepatic nuclear factor 1-alpha: inflammation, genetics, and atherosclerosis. (2009) (50)
Major clinical trials of hypertension: what should be done next? (2005) (50)
Does Milk Consumption Contribute to Cardiometabolic Health and Overall Diet Quality? (2016) (50)
Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. (1994) (49)
Charge properties of low density lipoprotein subclasses. (1997) (49)
Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility. (1999) (48)
Cardiovascular fitness, body composition, and lipoprotein lipid metabolism in older men. (2000) (48)
Changes in plasma lipoprotein distribution and formation of two unusual particles after heparin-induced lipolysis in hypertriglyceridemic subjects. (1979) (48)
Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. (1997) (48)
Relationship of dietary fat, protein, cholesterol, and fiber intake to atherogenic lipoproteins in men. (1986) (48)
Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome (2018) (48)
Pathophysiology of triglyceride‐rich lipoproteins in atherothrombosis: Clinical aspects (1999) (47)
Multi-Ethnic Analysis of Lipid-Associated Loci: The NHLBI CARe Project (2012) (47)
All low-density lipoprotein particles are not created equal. (2014) (46)
Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses. (1983) (46)
Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. (1991) (46)
Subclasses of Low-Density Lipoprotein and Very Low-Density Lipoprotein in Familial Combined Hyperlipidemia: Relationship to Multiple Lipoprotein Phenotype (2004) (45)
Response of plasma histaminase activity to small doses of heparin in normal subjects and patients with hyperlipoproteinemia. (1973) (44)
Behavioral Versus Genetic Correlates of Lipoproteins and Adiposity in Identical Twins Discordant for Exercise (2005) (44)
Quantification of HDL2 and HDL3 cholesterol by the Vertical Auto Profile-II (VAP-II) methodology. (1997) (43)
Reversal of Small, Dense LDL Subclass Phenotype by Normalization of Adiposity (2009) (43)
Summary of the Scientific Conference on the Efficacy of Hypocholesterolemic Dietary Interventions (1996) (43)
Genomic interval engineering of mice identifies a novel modulator of triglyceride production. (2000) (43)
Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women. (1988) (43)
Long-term reversible contraception with levonorgestrel-releasing Silastic rods. (1984) (43)
Cholesterol vehicle in experimental atherosclerosis. 23. Effects of specific synthetic triglycerides (2000) (42)
Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice. (1998) (42)
The associations of high-density lipoprotein subclasses with insulin and glucose levels, physical activity, resting heart rate, and regional adiposity in men with coronary artery disease: the Stanford Coronary Risk Intervention Project baseline survey. (1995) (41)
Determination and use of haplotypes: Ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans (2003) (41)
Lack of evidence for linkage between low‐density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia (1991) (41)
Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population (1980) (40)
Associations of diet and alcohol intake with high-density lipoprotein subclasses. (1985) (40)
Changes in serum high density lipoproteins in women on oral contraceptive drugs. (1977) (40)
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile (2014) (39)
Influence of protein and amino acids on food intake in the rat. (1965) (39)
Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. (2007) (39)
Public health guidelines should recommend reducing saturated fat consumption as much as possible: YES. (2020) (39)
Low-Density Lipoprotein Particle Size Loci in Familial Combined Hyperlipidemia: Evidence for Multiple Loci From a Genome Scan (2004) (39)
Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. (1996) (39)
Soy protein and serum lipids. (1995) (38)
Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content (2018) (38)
Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. (1999) (38)
Associations of lecithin: cholesterol acyltransferase (LCAT) mass concentrations with exercise, weight loss, and plasma lipoprotein subfraction concentrations in men. (1990) (37)
CYP3A4*22 and CYP3A5*3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort (2014) (37)
Levels of Cholesterol in Small LDL Particles Predict Atherosclerosis Progression and Incident CHD in the HDL-Atherosclerosis Treatment Study (HATS) (2013) (37)
Effects of progestational agents on serum lipids and lipoproteins. (1982) (37)
Polymorphisms in the peroxisome proliferator activated receptor alpha gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. (2008) (37)
Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease. (1993) (36)
Associations of resting heart rate with concentrations of lipoprotein subfractions in sedentary men. (1985) (36)
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance[S] (2019) (36)
Metabolic effects of nandrolone decanoate and resistance training in men with HIV. (2002) (36)
Changes in atherogenic dyslipidemia induced by carbohydrate restriction in men are dependent on dietary protein source. (2011) (36)
Positional specificity of triglyceride lipases in post-heparin plasma. (1973) (36)
Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits (2003) (35)
A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. (2013) (35)
Metabolism of Human Intermediate and Very Low Density Lipoprotein Subtractions from Normal and Dysbetalipoproteinemic Plasma: In Vivo Studies in the Rat (1987) (35)
Low plasma adropin concentrations increase risks of weight gain and metabolic dysregulation in response to a high-sugar diet in male nonhuman primates (2019) (35)
Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons. (2004) (35)
A genome-wide association analysis of temozolomide response using lymphoblastoid cell lines shows a clinically relevant association with MGMT (2012) (33)
Increased plasma concentrations of lipoprotein(a) during a low-fat, high-carbohydrate diet are associated with increased plasma concentrations of apolipoprotein C-III bound to apolipoprotein B-containing lipoproteins. (2007) (33)
Diets high in protein or saturated fat do not affect insulin sensitivity or plasma concentrations of lipids and lipoproteins in overweight and obese adults. (2014) (33)
Effects of simvastatin, an HMG‐CoA reductase inhibitor, in patients with hypertriglyceridemia (2003) (32)
RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin (2012) (32)
Meta-analysis of genome-wide association studies of HDL cholesterol response to statins (2016) (31)
Endurance training has little effect on active muscle free fatty acid, lipoprotein cholesterol, or triglyceride net balances. (2006) (31)
Linkage analysis of low‐density lipoprotein subclass phenotypes and the apolipoprotein B gene (1991) (31)
Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase. (1998) (29)
Reduced adipose tissue lipoprotein lipase responses, postprandial lipemia, and low high-density lipoprotein-2 subspecies levels in older athletes with silent myocardial ischemia. (1994) (29)
Plasma triglyceride concentrations are rapidly reduced following individual bouts of endurance exercise in women (2010) (29)
Relationship of Sex to Diabetes Risk in Statin Trials (2013) (28)
Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. (2010) (28)
Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma. (2002) (28)
Differing alpha-tocopherol oxidative lability and ascorbic acid sparing effects in buoyant and dense LDL. (1995) (28)
Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions. (2017) (28)
The effect on lipids and lipoproteins of a contraceptive vaginal ring containing levonorgestrel and estradiol. (1981) (27)
Exercise, lipoproteins, and coronary artery disease. (1989) (27)
Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. (1995) (27)
A nutrient‐dense, high‐fiber, fruit‐based supplement bar increases HDL cholesterol, particularly large HDL, lowers homocysteine, and raises glutathione in a 2‐wk trial (2012) (26)
Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation (2014) (26)
Interactions of high density lipoproteins with very low and low density lipoproteins during lipolysis. (1988) (26)
Solvent drag of LDL across mammalian endothelial barriers with increased permeability. (1995) (26)
Effects of dietary fat on high-density-lipoprotein subclasses are influenced by both apolipoprotein E isoforms and low-density-lipoprotein subclass patterns. (1995) (26)
A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women[S] (2010) (26)
Polyhedral 3D structure of human plasma very low density lipoproteins by individual particle cryo-electron tomography1[S] (2016) (26)
Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository. (2008) (25)
Effects of dietary saturated fat on LDL subclasses and apolipoprotein CIII in men (2012) (25)
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation (2021) (25)
Effect of pesticides on testicular function. (1978) (24)
A multi-ethnic genome-wide association study implicates collagen matrix integrity and cell differentiation pathways in keratoconus (2021) (24)
Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. (2004) (24)
Alternative splicing in the regulation of cholesterol homeostasis (2013) (24)
Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization. (2018) (24)
Impact of a 2-year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes (2020) (24)
Acute Overactive Endocannabinoid Signaling Induces Glucose Intolerance, Hepatic Steatosis, and Novel Cannabinoid Receptor 1 Responsive Genes (2011) (24)
LDL density and atherosclerosis. (1995) (24)
Public health guidelines should recommend reducing saturated fat consumption as much as possible: Debate Consensus. (2020) (23)
Cardiovascular disease and hyperlipidaemia. (1994) (23)
Public health guidelines should recommend reducing saturated fat consumption as much as possible: NO. (2020) (23)
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. (2012) (23)
Genetic, metabolic, and dietary influences on the atherogenic lipoprotein phenotype. (1997) (22)
Genome-wide association and pharmacological profiling of 29 anticancer agents using lymphoblastoid cell lines. (2014) (22)
The early years of lipoprotein research: from discovery to clinical application (2016) (22)
Effect of alpha- and selective beta-blockade for hypertension control on plasma lipoproteins, apoproteins, lipoprotein subclasses, and postprandial lipemia. (1989) (21)
Lipolysis products promote the formation of complexes of very-low-density and low-density lipoproteins. (1987) (21)
Lessons Learned from the POUNDS Lost Study: Genetic, Metabolic, and Behavioral Factors Affecting Changes in Body Weight, Body Composition, and Cardiometabolic Risk (2019) (21)
ATHENA: A Tool for Meta-Dimensional Analysis Applied to Genotypes and Gene Expression Data to Predict HDL Cholesterol Levels (2012) (21)
Effects of estrogens and progestins on high density lipoproteins (2006) (21)
Association/National Heart, Lung, and Blood Institute Scientific Statement Diagnosis and Management of the Metabolic Syndrome: An American Heart (2006) (21)
Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS) (2012) (21)
Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin. (2015) (21)
Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function. (2012) (21)
Therapeutic failure in familial type II hyperlipoproteinemia. (1976) (20)
High disaccharide intake associates with atherogenic lipoprotein profile (2011) (20)
The atherogenic lipoprotein phenotype is not caused by a mutation in the coding region of the low density lipoprotein receptor gene (1997) (20)
HDL and coronary artery disease. (1993) (20)
Selective resistance of LDL core lipids to iron-mediated oxidation. Implications for the biological properties of iron-oxidized LDL. (1996) (19)
Use of an electronic medical record to characterize cases of intermediate statin-induced muscle toxicity. (2009) (19)
Saturated Fats and Health: AReassessment and Proposal for Food-Based Recommendations (2020) (19)
Plasma clearance of human low-density lipoprotein in human apolipoprotein B transgenic mice is related to particle diameter. (2004) (19)
Relationship between resolution of non‐alcoholic steatohepatitis and changes in lipoprotein sub‐fractions: a post‐hoc analysis of the PIVENS trial (2019) (19)
Familial correlations of HDL subclasses based on gradient gel electrophoresis. (1992) (19)
Prepregnancy Adverse Lipid Profile and Subsequent Risk of Gestational Diabetes. (2016) (19)
Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects. (1994) (18)
Multivariate methods and software for association mapping in dose‐response genome‐wide association studies (2012) (18)
Cardiovascular pharmacogenomics. (2011) (17)
Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma Concentrations (2015) (17)
Determination and use of haplotypes: ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. (2003) (17)
Characterization of Statin Low-Density Lipoprotein Cholesterol Dose-Response Using Electronic Health Records in a Large Population-Based Cohort (2018) (17)
Lipids and Lipoproteins and Effects of Hormone Replacement (1992) (17)
Is the size of low-density lipoprotein particles related to the risk of coronary heart disease? (2002) (17)
Statin-induced changes in gene expression in EBV-transformed and native B-cells. (2014) (16)
Fructose-induced hypertriglyceridemia in rhesus macaques is attenuated with fish oil or ApoC3 RNA interference[S] (2019) (15)
Pharmacometabolomic signature links simvastatin therapy and insulin resistance (2016) (15)
Subclinical chronic pancreatitis in type I hyperlipoproteinemia. (1977) (15)
Transmembrane Protein 55B Is a Novel Regulator of Cellular Cholesterol Metabolism (2014) (15)
Single-molecule 3D imaging of human plasma intermediate-density lipoproteins reveals a polyhedral structure (2018) (15)
ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways (2019) (15)
Assessing the mechanisms of cholesteryl ester transfer protein inhibitors (2017) (14)
Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets (2021) (14)
Increased low density lipoprotein degradation in aorta of irradiated mice is inhibited by preenrichment of low density lipoprotein with alpha-tocopherol. (2000) (13)
Hold the antioxidants and improve plasma lipids? (2004) (13)
Ancestry and other genetic associations with plasma PCSK9 response to simvastatin (2014) (13)
Dietary Starch, Dietary Sucrose and Hepatic Pyruvate Kinase in Rat (1967) (13)
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study (2019) (13)
Dietary Saturated Fats and Health: Are the U.S. Guidelines Evidence-Based? (2021) (12)
Lipoprotein Candidate Genes for Multivariate Factors of the Insulin Resistance Syndrome: A Sib-pair Linkage Analysis in Women Twins (2001) (12)
Low-fat diets, lipoprotein subclasses, and heart disease risk. (1999) (12)
A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements (2015) (12)
Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome (2011) (12)
Dietary and genetic effects on LDL heterogeneity. (2001) (12)
Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels 1. (2005) (12)
Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response. (2008) (12)
Association of the APOLIPOPROTEIN A 1 / C 3 / A 4 / A 5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia (2004) (12)
Lipid metabolism in children and adolescents: Impact on vascular biology. (2008) (12)
Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL. (2020) (11)
Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels (2004) (11)
Correction: Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment (2013) (11)
Differential effects of ramipril on ambulatory blood pressure in African Americans and Caucasians. (2007) (11)
Individualized hormone-replacement therapy? (2002) (11)
Association study of androgen signaling pathway genes in polycystic ovary syndrome. (2016) (11)
A randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity (2019) (10)
Influence of apoE content on receptor binding of large, bouyant LDL in subjects with different LDL subclass phenotypes. (1998) (10)
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatment. (2016) (10)
PharmGKB summary: very important pharmacogene information for RYR1 (2016) (10)
CNR1 Genotype Influences HDL-Cholesterol Response to Change in Dietary Fat Intake (2012) (10)
Genetic nondiscrimination legislation: a critical prerequisite for pharmacogenomics data sharing. (2007) (9)
A unified framework identifies novel links between plasma lipids and diseases from electronic medical records across large-scale cohorts (2021) (9)
Understanding the basis for variation in response to cholesterol-lowering diets. (1997) (9)
What can the genome tell us about LDL cholesterol? (2008) (9)
Overfeeding of Polyunsaturated Versus Saturated Fatty Acids Reduces Ectopic Fat (2014) (9)
The editor's roundtable: expanded versus standard lipid panels in assessing and managing cardiovascular risk. (2008) (9)
The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change (2020) (9)
Gene-Diet Interactions in Lipoprotein Metabolism1 (1992) (9)
Phospholipid transfer protein and atherosclerosis: genetic studies take aim at a moving target. (2010) (9)
Reversal of Small, Dense LDL Subclass Phenotype by Weight Loss Is Associated With Impaired Fat Oxidation (2011) (9)
Low-Density Lipoprotein Particle Number Is Associated With Cardiovascular Events Among Those Not Classified Into Statin Benefit Groups. (2015) (9)
Hold the antioxidants and improve plasma lipids (2004) (9)
Familial factors in the antihypertensive response to lisinopril. (2001) (9)
Pathophysiology of triglyceride-rich particles. A. Metabolism of triglyceride-rich particles. (1991) (8)
Effect of SLCO1B1 T521C on Statin‐Related Myotoxicity With Use of Lovastatin and Atorvastatin (2021) (8)
Genetic recipes for heart-healthy diets. (2000) (8)
Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi[S] (2020) (8)
1. Pathophysiology of triglyceride-rich particles (1991) (8)
A Randomized Study of the Effect of Replacing Sugar-Sweetened Soda by Reduced Fat Milk on Cardiometabolic Health in Male Adolescent Soda Drinkers (2020) (8)
Genetic variants modulate gene expression statin response in human lymphoblastoid cell lines (2020) (8)
Erratum: Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System: A Report From the Workshop Convened by the World Heart Federation (J Am Coll Cardiol (2015) 66 (1590-1614)) (2015) (7)
Variations in high-density lipoprotein subclasses during the menstrual cycle. (1994) (7)
Contraceptive Steroid Effects on Serum Lipoproteins and Lipoprotein Subclasses (1986) (7)
Insulin resistance syndrome and dyslipidemia. (2003) (7)
Genetic epidemiology of low density lipoprotein subclasses a common allele predisposing to coronary heart disease (1986) (6)
Size transformations of intermediate and low density lipoproteins induced by unesterified fatty acids. (1991) (6)
Expanding Precompetitive Multisector Collaborations to Advance Drug Development and Pharmacogenomics (2019) (6)
Lipoprotein candidate genes for multivariate factors of the insulin resistance syndrome: a sib-pair linkage analysis in women twins. (2001) (6)
Low-Density Lipoprotein Particle Size Subfractions and Cerebral Amyloidosis. (2019) (6)
Unique structural properties of apolipoprotein B in low-density lipoproteins produced by several human hepatoma-derived cell lines. (1990) (6)
Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults (2021) (6)
Metabolic interrelationships of HDL subclasses. (1986) (6)
Analysis and quantitation of biotinylated apoB-containing lipoproteins with streptavidin-Cy3 DOI 10.1194/jlr.D100337-JLR200 (2002) (6)
Selective Measurement of Lipoprotein Lipase and Hepatic Lipase in Post-Heparin Plasma (1974) (6)
Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting. (2014) (6)
Reply to P Scarborough et al (2010) (6)
Specific increase in a high density lipoprotein subfraction in women using birth control pills. (Abstract only) (1969) (6)
The impact of adjusting for baseline in pharmacogenomic genome-wide association studies of quantitative change (2020) (5)
Apolipoprotein and size heterogeneity in human umbilical cord blood low density lipoproteins. (1983) (5)
Alcohol and the heart: does raising high-density lipoprotein matter? (2011) (5)
Mangravite et al. reply (2014) (5)
Effects of Palm Stearin versus Butter in the Context of Low-Carbohydrate/High-Fat and High-Carbohydrate/Low-Fat Diets on Circulating Lipids in a Controlled Feeding Study in Healthy Humans (2021) (5)
Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2 (2021) (5)
Lipoprotein subclasses in genetic studies: The Berkeley data set (1993) (5)
ZNF542P is a pseudogene associated with LDL response to simvastatin treatment (2018) (5)
Saturated fat and heart disease. Authors' reply (2010) (4)
Phosphatidylinositol-(4,5)-Bisphosphate Regulates Plasma Cholesterol Through LDL (Low-Density Lipoprotein) Receptor Lysosomal Degradation (2020) (4)
Lipoprotein Particle Predictors of Arterial Stiffness after 17 Years of Follow Up: The Malmö Diet and Cancer Study (2020) (4)
Increased immunoreactivity of apolipoprotein B epitopes during prolonged storage of low density lipoproteins. (1990) (4)
Association of a genetic polymorphism in human apolipoprotein B‐100 with intermediate density lipoprotein concentrations (1991) (4)
Preventing heart attack and death in patients with coronary disease. Endorsed by the board of trustees of the American College of Cardiology. (1996) (4)
Randomized nutrient bar supplementation improves exercise-associated changes in plasma metabolome in adolescents and adult family members at cardiometabolic risk (2020) (4)
Variability of plasma HDL subclass concentrations in men and women over time. (1997) (3)
Energy Substrate Partitioning and Efficiency in Individuals With Atherogenic Lipoprotein Phenotype (2011) (3)
Genetic and metabolic influences on LDL subclasses (1994) (3)
Small dense low-density lipoprotein particles: clinically relevant? (2022) (3)
AHA conference proceedings. Summary of the scientific conference on the efficacy of hypocholesterolemic dietary interventions. American Heart Association. (1996) (3)
The American College of Physicians guidelines for screening blood cholesterol levels: a commentary. (1998) (3)
Endogenous Sex Steroid Hormones, Lipid Subfractions, and Ectopic Adiposity in Asian Indians. (2015) (3)
AHA Medical / Scientific Statement Position Statement Cardiac Rehabilitation Programs A Statement for Healthcare Professionals From the American Heart Association Writing Group (2005) (3)
Lawrence Berkeley National Laboratory Recent Work Title Polyhedral 3 D structure of human plasma very low density lipoproteins by individual particle cryo-electron tomography 1 (2016) (3)
CorrectionSIRT7 Represses Myc Activity to Suppress ER Stress and Prevent Fatty Liver Disease (2013) (3)
Differences in carbohydrate content of low density lipoprotein subclasses (1988) (2)
ATHEROGENECITY OF TRIGLYCERIDE-RICH LIPOPROTEIN (1998) (2)
Which cheese to choose? (2016) (2)
Elevated LDL-cholesterol levels among lean mass hyper-responders on low-carbohydrate ketogenic diets deserve urgent clinical attention and further research. (2022) (2)
Genetic recipes for heart-healthy diets (Editorial) (2000) (2)
WHO draft guidelines on dietary saturated and trans fatty acids: time for a new approach? (2019) (2)
Genetic influences on lipoprotein response to dietary fat and cholesterol: overview (1995) (2)
Impact of A Two-Year Trial of Nutritional Ketosis on Indices of Cardiovascular Disease Risk in Patients With Type 2 Diabetes (2020) (2)
The obesity problem. (1998) (2)
Oral Contraceptives and Plasma Lipoprotein Metabolism (1993) (2)
Pharmacometabolomic signature links simvastatin therapy and insulin resistance: an addition to the topical collection “Recent Advances in Pharmacometabolomics: Enabling Tools for Precision Medicine” (2017) (1)
Dyslipidemic syndromes and atherosclerosis: recent advances and challenges for the future (1995) (1)
Abstract 15433: Lpa Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins Abstract (2017) (1)
Dietary Carbohydrate Restriction in the Management of NAFLD and Metabolic Syndrome (2017) (1)
Small LDL, elevated triglycerides and increased homocysteine response to a methionine load identify a high-risk restenosis group (1994) (1)
Reply to MB Katan et al (2010) (1)
Lipolytic Activities of Hepatic Plasma Membrane Origin in Postheparin Plasma (1974) (1)
Compartmentalization of oxidative injury in low density lipoproteins (LDL): Evidence for two kinetic pools corresponding to the LDL surface monolayer and hydrophobic core (1993) (1)
Abstract 630: Pcsk9 Deficiency Reduces Atherosclerosis, Apolipoprotein B Secretion, Lipogenesis and Endothelial Dysfunction (2018) (1)
Abstract: P1392 EFFECTS OF THE CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR ANACETRAPIB ON LIPOPROTEIN SUBFRACTIONS (2009) (1)
Dietary and Genetic Effects on Atherogenic Dyslipidemia (2006) (1)
The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction (2022) (1)
Dietary sodium and blood pressure. (1996) (1)
Effects of hormones on lipids and lipoproteins (1991) (1)
In Memoriam: Alexander V. Nichols (1924–2015) (2015) (1)
Characterization of remnant-like lipoprotein particles isolated by immunoaffinity gel from subjects with LDL subclass phenotypes A and B (1999) (1)
Recognising placental steroid sulphatase deficiency. (1983) (1)
The effects of oral contraceptives on plasma lipids and lipoproteins. (1988) (1)
Abstract 15525: Alirocumab, a Fully Human Monoclonal Antibody to Proprotein Convertase Subtilisin/kexin Type 9, and Its Effects on Lipoprotein Subfractions Determined by Ion Mobility (2014) (1)
Discovery and Refinement Supplementary (2015) (1)
Lipoproteins and coronary heart disease. (1989) (0)
Behavioral versus genetic determination of lipoproteins and adiposity in identical twins discordant for exercise (2004) (0)
The Mediterranean Diet to Prevent Type 2 Diabetes and Cardiovascular Disease (2017) (0)
A Collaborative Approach for Cardiovascular Health Promotion for Children and Youth : A Population and Public Health Perspective (2005) (0)
Reply to EC Westman et al (2006) (0)
W16-P-075 Effects of combined estrogen+progestin hormone therapy on hepatic lipase and lipoprotein lipase levels (2005) (0)
Correction to: Impact of a 2‑year trial of nutritional ketosis on indices of cardiovascular disease risk in patients with type 2 diabetes (2021) (0)
Abstract 590: LDL Particle Number is Associated With Incident Atherosclerotic Cardiovascular Disease Among Persons With a 10-Year Risk of <7.5% (2014) (0)
Abstract 17812: Lipoprotein Subspecies Predict Arterial Stiffness (2016) (0)
Dense LDL and Coronary Artery Disease (1994) (0)
Effects of low‐fat, high‐carbohydrate diet on plasma lipoprotein(a) and oxidized phospholipids (2010) (0)
Behavioral versus genetic determination of lipoproteins andidentical twins discordant for exercise (2004) (0)
Supplementary Material (nature09270-s1) (2012) (0)
Validation of Electronic Health Records for the Assessment of Statin Dosing In Research (2017) (0)
Genetic influences on dietary fat-induced changes in low density lipoprotein subclass phenotypes (1999) (0)
Pharmacometabolomic signature links simvastatin therapy and insulin resistance (2016) (0)
Abstract 12151: PCSK9 Mediates Atherogenesis (2016) (0)
56 NONFASTING BLOOD CONCENTRATION OF LIPOPROTEIN SUBFRACTIONS AND RISK OF CORONARY HEART DISEASE IN A SWEDISH NESTED CASE-CONTROL STUDY (2011) (0)
Effects of Dietary Trans Fatty Acids on Cardiovascular Risk (2017) (0)
Abstract: 1471 GENETIC REGULATION OF ALTERNATIVE SPLICING OF HMGCOA REDUCTASE IS ASSOCIATED WITH VARIATION IN LDL RESPONSE TO STATIN TREATMENT (2009) (0)
Small dense LDL in the evaluation and management of coronary artery disease risk (2000) (0)
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter? (2022) (0)
Nutrition and Cardiometabolic Health (2017) (0)
TABLE I I I Plasma Triglyceride and Cholesterol Levels in Hypertriglyceridemic Subjects on High Carbohydrate Diet Day of minimal Day of maximal Preinduction cholesterol value triglyceride value End of induction End of fast Patient (0)
Altered Activities of Anti-atherogenic Enzymes Lecithin:cholesterol Acyltransferase, Paraoxonase and Platelet-activating Factor Acetylhydrolase in Atherosclerosis Susceptible Mice (2002) (0)
Association of body mass index with DNA methylation and gene expression in blood cells and relations to cardiometabolic disease (2017) (0)
Utility of novel markers for coronary artery disease riskassessment in healthy people (2000) (0)
Symposium : Nutritional and Metabolic Diversity : Understanding the Basis of Biologic Variance in the Obesity / Diabetes / Cardiovascular Disease Connection Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions 1 , 2 (2001) (0)
CRADA Final Report: Genetic Testing for Evaluation of Heart Disease Risk (2002) (0)
Omega-3 and Omega-6 Fatty Acids* : Roles in Cardiometabolic Disease (2017) (0)
Gut Microbiome : Its Relationship to Health and Its Modulation by Diet (2017) (0)
Metabolic recipes for heart disease prevention (1996) (0)
Abstract # 10083: From Genotype to Phenotype at a Novel Cholesterol and Myocardial Infarction Locus (2010) (0)
Time-Dependent Instability of Cardiac Troponins in Human Plasma Spiked with NIST Reference Material (2008) (0)
Dislipemia en diabetes tipo 2 (2004) (0)
Explorer Epigenetic patterns in blood associated with lipid traits predict incident coronary heart disease events and are enriched for results from genome-wide association studies (2017) (0)
High density lipoproteins (HDL) : I. structure, function, and analysis. II. clinical, epidemiological, and metabolic aspects : symposium : presented at the American Oil Chemists' Society annual meeting, St. Louis, Missouri, May 15-16, 1978 (1979) (0)
Saturated fat, carbohydrate, and cardiovascular disease 1–4 (2010) (0)
Pathophysiology of triglyceride-rich lipoproteins in atherothrombosis : Cellular aspects. Discussion (1999) (0)
Oral Contraceptives Effect on Lipid Metabolism (1992) (0)
Effect of L-Citrulline on Muscle Recovery after Anaerobic and Aerobic Exercise (2015) (0)
Dietary Starches and Grains: Effects on Cardiometabolic Risk (2017) (0)
A randomized, controlled trial on the effects of almonds on lipoprotein response to a higher carbohydrate, lower fat diet in men and women with abdominal adiposity (2019) (0)
Lipids and Lipoproteins and Effects of Hormone Therapy (2007) (0)
Effects of Diet on Cardiovascular Disease Risk (2007) (0)
Rooted in risk ; genetic predisposition for LDL-c level associates with diminished LDL-c response to statin treatment (2016) (0)
Standardization of advanced lipoprotein testing: The BioSITrace project (2019) (0)
Abstract 183: Association of LDL Particles With Cerebral Amyloidosis (2018) (0)
The Effects of Oral Contraceptives on Lipid Metabolism (1986) (0)
Do lipoprotein subclass tests increase treatment rates in high-risk patients? (2003) (0)
Non-Alcoholic Steatohepatitis Resolution is Associated with Improvements in LDL Size and Phenotype (2016) (0)
Abstract 159: Sex Differences in the Association of Lipoprotein(a) with Subclinical Atherosclerosis in a South Asian Population (2015) (0)
Polygenic risk score and statin relative risk reduction for primary prevention in a real-world population (2021) (0)
Ion Mobility Lipoprotein Analysis (2020) (0)
Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort (2022) (0)
Atorvastatin Dose‐response for High‐density Lipoprotein Cholesterol in a Population‐Based DNA Biobank Cohort (2008) (0)
Plasma histaminase activity after heparin in normal subjects and patients with hyperlipoproteinemia (1973) (0)
Composite Phenotypes of Interrelated Lipoprotein Subclasses Independently Predict Diet‐Induced Changes in Plasma Lipids and Lipoproteins (2009) (0)
Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile (2014) (0)
Abstract: 515 MBX8025, A NOVEL PPARΔ AGONIST: LIPID & METABOLIC EFFECTS IN DYSLIPIDEMIC OVERWEIGHT PATIENTS (2009) (0)
TRANSCRIPTOME 2000 : From Functional Genomics to Systems Biology (2018) (0)
Principles of Pharmacogenetics and Pharmacogenomics: Statin-Induced Muscle Toxicity (2012) (0)
Lawrence Berkeley National Laboratory Recent Work Title Polyhedral (2017) (0)
INTERACTION BETWEEN OBESITY, BRAIN HDL, AND APOE4 GENOTYPE IN CEREBRAL AMYLOIDOSIS (2019) (0)
Issues and Opinions in Nutrition AHA Scientific Statement : Summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health 1 Conference Summary From the Nutrition Committee of the American Heart Association Conference Planning and Writing Committee : (2001) (0)
Low estrogen containing oral contraceptives alter lipoprotein phospholipid and increase mononuclear cell membrane fluidity (1985) (0)
Antenatal micronutrients in undernourished people (2008) (0)
Wissenschaftliches Symposium "Saturated Fat and Heart Disease: What's the Evidence?" (2008) (0)
Effects and Mechanisms of Fructose-Containing Sugars in the Pathophysiology of Metabolic Syndrome (2017) (0)
Development of a ProtonNuclearMagneticResonanceSpectroscopic Methodfor DeterminingPlasmaLipoprotein Concentrations and SubspeciesDistributions froma Single,RapidMeasurement (1992) (0)
Concerns regarding NMR lipoprotein analyses performed on the nightingale heath platform - Focus on LDL subclasses. (2022) (0)
Lipids: Part of the Tangled Web (1992) (0)
The metabolic impact of oral contraceptives (1993) (0)
The metabolic effects of a low-estrogen/low-progestogen oral contraceptive. (1981) (0)
Reply to JJ Kenney et al (1999) (0)
Pharmacogenomics of statin response. (2008) (0)
Abstract 630: Lipoprotein Subclasses by Ion Mobility and First Cardiovascular Events: An Analysis of 11,227 Participants From the JUPITER Trial (2014) (0)
Points: Recognising placental steroid sulphatase deficiency (1983) (0)
Hyperlipidemias: Major Gene and Diet Effects (2007) (0)
MOLECULAR AND CELL BIOLOGY: ABETA/AMYLOID O3-01-01 INTERACTION BETWEEN OBESITY, BRAIN HDL, AND APOE4 GENOTYPE IN CEREBRAL AMYLOIDOSIS CHRONIC BEHAVIORAL AND NEUROPATHOLOGICAL PHENOTYPES IN WILD-TYPE AND APP/PS1 MICE (2019) (0)
Abstract 46: Cholesteryl Ester Transfer Protein Interactions with Lipoproteins: Insights into Mechanisms by Electron Microscopy and Molecular Dynamics Simulation (2012) (0)
Changes in LDL size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions (2018) (0)
Abstract 397: Changes in Lipoprotein Subfraction Concentrations After Treatment with the Cholesteryl Ester Transfer Protein Inhibitor Anacetrapib Alone or in Combination with Atorvastatin (2013) (0)
Oxidative Liability of {Alpha}-Tocopherol Differs in Buoyant andDens e LDL and is Affected by High Monounsaturated Fat Diets (1995) (0)
PLASMA LIPOPROTEINS AND POLYUNSATURATED (P) VERSUS MONOUNSATURATED (M) REDUCED-FAT DIETS (1988) (0)
Abstract P217: Metabolic Effects of a Nutrient-Dense High Fiber Supplement (2012) (0)
Nutrient-gene interactions in carbohydrate and lipid metabolism: unraveling the tangled web (1995) (0)
126-OR: MIR192-5p Is a Novel Regulator of GLP-1R and Insulin Secretion That May Contribute to Risk of Statin-Induced Diabetes (2021) (0)
Human knockouts and phenotypic analysis 1 in a cohort with a high rate of consanguinity 2 3 (2016) (0)
Multicomponent Nutrient Bar Promotes Weight Loss and Improves Dyslipidemia and Insulin Resistance (2019) (0)
Abstract 524: Role of Transmembrane Protein 55B in Insulin Signaling and Hepatic Lipid Metabolism (2015) (0)
Correction: RHOA Is a Modulator of the Cholesterol-Lowering Effects of Statin (2013) (0)
Saturated Fats, Cholesterol, and Cardiovascular Disease (2014) (0)
LDL subclass pattern and apolipoprotein E isoform phenotype in lipoprotein response to a reduced-fat diet. (1996) (0)
Abstract 529: High-dimensional Genetic Analysis of Lipoprotein Composition and Size in the Mouse (2015) (0)
Type I lipoproteinemia and the pancreas (1978) (0)
Abstract 14943: Comparison of Fasting and Nonfasting Lipoprotein Subfractions and Size in 13,460 Apparently Healthy Individuals (2017) (0)
157 Myeloid expression of trib1 regulates the polarisation state of tissue resident macrophages that has consequences on plasma lipid and metabolic homeostasis (2017) (0)
Carbohydrate-Induced Hypertriglyceridemia (0)
Interaction of Dietary Protein and Energy Balance (2017) (0)
Improvements to the method of lipoprotein analysis by NMR (1994) (0)
Abstract 198: The Role of PI(4,5)P 2 in LDL Receptor Lysosomal Decay (2018) (0)
Pharmacogenetic GWAS meta-analysis of LDL cholesterol response to statins (2014) (0)
Abstract P348: The Effects of High Saturated Fat Intake on LDL and HDL Subclasses in Individuals with Atherogenic Dyslipidemia (2012) (0)
ION Mobility Analysis Of Lipoprotein Subfractions Suggests Three Independent Mechanisms Of Cardiovascular Risk (2009) (0)
Abstract 19434: Smaller Ldl Peak Diameter is Causally Associated With Higher Risk of Coronary Heart Disease (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Ronald M Krauss?

Ronald M Krauss is affiliated with the following schools: